ProfileGDS5822 / ILMN_2589256
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 69% 70% 73% 69% 71% 78% 75% 80% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 191.876
GSM1276600PDAC Late Ablation Control 251.869
GSM1276601PDAC Late Ablation Control 375.170
GSM1276602PDAC Late Ablation 164.773
GSM1276603PDAC Late Ablation 251.969
GSM1276604PDAC Late Ablation 363.171
GSM1303940PDAC Late Ablation_anti-CTLA4 1102.578
GSM1303941PDAC Late Ablation_anti-CTLA4 2114.875
GSM1303942PDAC Late Ablation_anti-CTLA4 3179.480